LON:VRCI

Verici Dx (VRCI) Share Price, News & Analysis

GBX 8
0.00 (0.00%)
(As of 04/23/2024 ET)
Today's Range
7.50
8
50-Day Range
7.73
11.79
52-Week Range
5.50
19
Volume
208,557 shs
Average Volume
357,168 shs
Market Capitalization
£19.40 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
VRCI stock logo

About Verici Dx Stock (LON:VRCI)

Verici Dx plc, an immuno-diagnostics development company, focuses on the kidney transplantation market. The company develops prognostic and diagnostic tests for kidney transplant patients. Its lead products comprise Tutivia, a post-transplant test focused on acute rejection, including sub-clinical rejection; and Clarava, a pre-transplant prognosis test for the risk of early acute rejection. The company also develops Protega, a peripheral blood-based test that aims to predict the risk of fibrosis and long-term graft failure. Verici Dx plc was incorporated in 2020 and is based in Penarth, the United Kingdom.

VRCI Stock Price History

VRCI Stock News Headlines

Verici Dx (LON:VRCI) Trading Down 0.3%
Verici Dx PLC Ordinary Shares VRCI
Thousands of investors use this no cost solution | Do you?
In today’s volatile markets we are all looking for the edge. But imagine tapping into a world where every investment move has the potential to be ahead of the curve. Most investors have heard of the publication Insider Financial. For nearly a decade, they've unlocked doors to opportunities tucked away from the public eye, guiding over a million investors with well researched information before it hits the mainstream media.
Verici Dx PLC Ordinary Shares
Verici Dx plc (63V.F)
DX - Dynex Capital, Inc.
Here’s how to start a “Weekend Side Hustle” from your sofa
Here’s how you can start your very own “Weekend Side Hustle” right from the comfort of your sofa! It doesn't matter if you have a multi-million dollar retirement account… Or if you’re just starting out with a few thousand.
Verici Dx plc (VRCI.L)
Verici Dx Share Chat
Verici Dx Plc (VRCI)
See More Headlines
Receive VRCI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Verici Dx and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Diagnostics & Research
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
14
Year Founded
N/A

Profitability

Net Income
£-11,210,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Cash Flow
GBX 6.09 per share
Book Value
GBX 4 per share

Miscellaneous

Free Float
N/A
Market Cap
£19.40 million
Optionable
Not Optionable
Beta
1.48
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

  • Ms. Sara Barrington A.C.A. (Age 57)
    A.C.I.M., CEO & Executive Director
    Comp: $281.77k
  • Mr. David M. Anderson (Age 61)
    Chief Financial Officer
  • Mr. Salim Gulamabbas Hamir F.C.A.
    Company Secretary

VRCI Stock Analysis - Frequently Asked Questions

How have VRCI shares performed in 2024?

Verici Dx's stock was trading at GBX 9.75 at the beginning of the year. Since then, VRCI stock has decreased by 17.9% and is now trading at GBX 8.
View the best growth stocks for 2024 here
.

How do I buy shares of Verici Dx?

Shares of VRCI stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:VRCI) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners